Pivaris BioScience GmbH

Founded

2019

Staff

1

Organization type

RDM biotech/pharma

Region

Vienna

Cluster

LISAvienna

R&D:A novel, broad-acting antiviral peptide targeting double-stranded DNA viruses such as herpes simplex virus, cytomegalovirus, vaccinia virus, polyomavirus and adenoviruses has been identified. This first-in-class inhibitor is currently being optimized and evaluated for its use in the systemic treatment of infections caused by double-stranded DNA viruses. The proprietary lead candidate of Pivaris BioScience GmbH is also being evaluated for its efficacy against various RNA viruses.